E.R. Squibb & Sons, L.L.C. drugs

18 results
  • augtyro - repotrectinib capsule

    (Repotrectinib)
    E.R. Squibb & Sons, L.L.C.
    Augtyro treats adults with locally advanced or metastatic ROS1-positive non-small cell lung cancer. It also treats adults and patients aged 12+ with locally advanced or metastatic NTRK gene fusion-positive solid tumors that have progressed on prior treatment or have no satisfactory alternative therapy.
  • eliquis - apixaban tablet, film coated

    (Apixaban)
    E.R. Squibb & Sons, L.L.C.
    Eliquis is a factor Xa inhibitor used in adults to reduce stroke risk in nonvalvular atrial fibrillation, prevent DVT after hip/knee surgery, and treat/prevent recurrent DVT and PE. Also indicated for VTE treatment and recurrence reduction in pediatric patients after initial anticoagulation.
  • empliciti - elotuzumab injection, powder, lyophilized, for solution

    (Elotuzumab)
    E.R. Squibb & Sons, L.L.C.
    Empliciti treats multiple myeloma in adults, combined with lenalidomide and dexamethasone after one to three prior therapies, or with pomalidomide and dexamethasone after at least two prior therapies including lenalidomide and a proteasome inhibitor.
  • evotaz - atazanavir and cobicistat tablet

    (Atazanavir And Cobicistat)
    E.R. Squibb & Sons, L.L.C.
    EVOTAZ combines atazanavir (HIV-1 protease inhibitor) and cobicistat (CYP3A inhibitor) for treating HIV-1 infection in adults and pediatric patients weighing at least 35 kg, used alongside other antiretroviral agents. Treatment-experienced patients should be guided by baseline protease inhibitor resistance substitutions.
  • nulojix - belatacept injection, powder, lyophilized, for solution

    (Belatacept)
    E.R. Squibb & Sons, L.L.C.
    Nulojix (belatacept) prevents organ rejection in EBV-seropositive adults receiving a kidney transplant. Used with basiliximab, mycophenolate mofetil, and corticosteroids. Not indicated for non-kidney transplants.